Transcriptional regulation of human papillomavirus type 18 P105 promoter by the co-activator CBP

Intervirology

Volumn 50, Issue 6, 2008, Pages 418-425

  Valencia Hernández, Armando ^a   Cuevas Bennett, Christian ^b   Garrido, Efraín ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

CBP co activator; Human papillomavirus early promoter; SP1 factor

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CANCER CELL; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; VIRUS GENE;

CELLS, CULTURED; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 18; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRIDAE;

EID: 39749103455     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112917     Document Type: Article

References (47)

1. Frattini MG, Lim HB, Doorbar J, Laiminis LA: Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol 1997;71:7068-7072.
2. Geisen C, Kahn T: Promoter activity of sequences located upstream of the human papillomavirus types of 16 and 18 late regions. J Gen Virol 1996;77:2193-2200.
3. Tan W, Felber BK, Zolotukhin AS, Pavlakis GN, Schwartz S: Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis acting transactivation element of simian retrovirus type 1. J Virol 1995;69:5607-5620.
4. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-114.
5. zur Hausen H: Viruses in human cancers. Science 1991;254:1167-1173.
6. zur Hausen H: Papillomavirus infections a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-F78.
7. DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD: Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit Rev Oncog 1993;4:337-360.
8. Butz K, Hoppe-Seyler F: Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol 1993;67:6476-6486.
9. Thierry F, Spyrou G, Yaniv M, Howley PM: Two AP1 sites binding Jun B are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992;66:3740-3748.
10. Boam DS, Davidson I, Chambon P: A TATA-less promoter containing binding sites for ubiquitous transcription factors mediates cell type-specific regulation of the gene for transcription enhancer factor-1 (TEF-1). J Biol Chem 1995;270:19487-19494.
11. Mack DH, Laimins LA: A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl Acad Sci USA 1991;88:9102-9106.
12. Bouallaga I, Teissie S, Yaniv M, Thierry F: HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity. Mol Cell Biol 2003;23:2329-2340.
13. Chan WK, Klock G, Bernard HU: Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 1989;63:3261-3269.
14. Bauknecht T, Angel P, Royer HD, zur Hausen H: Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J 1992;11:4607-4617.
15. Hoppe-Seyler F, Butz K, zur Hausen H: Repression of the papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol 1991;65:5613-5618.
16. Kumar AP, Butler AP: Serum response gene expression mediated by Sp1. Biochem Biophys Res Commun 1998;255:517-523.
17. Chirivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH: Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993;365:855-859.
18. Bannister AJ, Kouzarides T: CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J 1995;14:4758-4762.
19. Kitabayashi I, Eckner R, Arany Z, Chiu R, Gachelin G, Livingston DM, Yokoyama K: Phosphorylation of the adenovirus E1A-associated 300 KDa protein in response to retinoic acid and E1A during differentiation of F9 cells. EMBO J 1995;14:3496-3509.
20. Missero C, Colautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto PG: Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995;92:5451-5455.
21. Martínez-Balbás MA, Bannister AJ, Martin K, Haus-Seuffert P, Meisterernst M, Kouzarides T: The acetyltransferase activity of CBP stimulates transcription. EMBO J 1998;17:2886-2893.
22. Gu W, Roeder RG: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997;22:595-606.
23. Hung HL, Lau J, Kim AY, Weiss MJ, Blobel GA: CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol 1999;19:3496-3505.
24. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans R: Role of CBP/p300 in nuclear receptor signalling. Nature 1996;383:99-103.
25. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997;90:569-580.
26. Blanco JC, Minucci S, Lu J, Yang XJ, Walker KK, Chen H, Evans RM, Nakatani Y, Ozato K: The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 1998;12:1638-1651.
27. Nakajima T, Uchida C, Anderson SF, Parvin JD, Montminy M: Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev 1997;11:738-747.
28. Brons-Poulsen J, Petersen NE, Horder M, Kristiansen K: An improved PCR-based method for site mutagenesis using megaprimers. Mol Cell Probes 1998;12:345-348.
29. Wigler M, Silverstein S, Lee LS, Pellicer A, Cheng Y, Axel R: Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 1977;11:223-232.
30. Jordan M, Schallhorm A, Wurm FM: Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucl Acids Res 1996;24:596-601.
31. Patel D, Huang SM, Baglia LA, McCance DJ: The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 1999;18:5061-5072.
32. Zimmermann H, Degenkolbe R, Bernard HU, O'Connor MJ: The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 1999;73:6209-6219.
33. Bouallaga I, Massicard S, Yaniv M, Thierry F: An enhanceosome containing the JunB/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV18 transcription. EMBO Rep 2000;1:422-427.
34. Hoppe-Seyler F, Butz K: Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Nucl Acids Res 1992;20:6701-6706.
35. Ralph WM Jr, Liu K, Auborn KJ: CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site. J Gen Virol 2006;87:51-59.
36. Bauknecht T, Jundt F, Herr I, Oehler T, Delius H, Shi Y, Angej P, zur Hausen H: A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J Virol 1995;69:1-12.
37. Liu Z, Simpson ER: Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol Cell Endocrinol 1999;153:183-196.
38. Wells J, Farnham PJ: Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 2002;26:48-56.
39. Weinmann AS, Bartley SM, Zhang T, Zhang MQ, Farnham PJ: Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 2001;21:6820-6832.
40. Weinmann AS, Farnham PJ: Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 2002;26:37-47.
41. Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, Marmorstein R, Berger SL: Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell 2000;5:917-926.
42. Mizzen CA, Allis CD: Linking histone acetylation to transcriptional regulation. Cell Mol Life Sci 1998;54:6-20.
43. Chen H, Li B, Workman JL: A histone-binding protein, nucleoplasmin, stimulates transcription factor binding to nucleosomes and factor-induced nucleosome disassembly. EMBO J 1994;13:380-390.
44. Pugh BF, Tjian R: Mechanism of transcriptional activation by Sp1: evidence for co-activators. Cell 1990;61:1187-1197.
45. Lefebvre O, Steger G, Yaniv M: Synergistic transcriptional-activation by the papillomavirus E2 protein occurs after DNA binding and correlates with a change in chromatin structure. J Mol Biol 1997;266:465-478.
46. Stunkel K, Bernard HU: The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol 1999;73:1918-1930.
47. O'Connor MJ, Tan SH, Tan CH, Bernard HU: YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 1996;70:6529-6530.